Tazemetostat(Tazverik)

Tazemetostat is the world’s first orally administered, selective EZH2 (enhancer of zeste homolog 2) inhibitor approved for marketing, and it belongs to epigenetic targeted therapeutic agents.

200mg*80tablets

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Tazemetostat Medication Guide

Important Considerations and Special Populations for Tazemetostat

Indications of TazemetostatTazemetostat is a methyltransferase inhibitor indicated for the treatment of:Adults and pediatric patients aged 16 years an···【Read More】
Update: 10 Mar,2026Source: Haiou HealthViews: 71
What Is Tazemetostat Used For

Overview of TazemetostatTazemetostat is an oral EZH2 inhibitor indicated for the treatment of:Relapsed or refractory follicular lymphoma (FL) in patie···【Read More】
Update: 10 Mar,2026Source: Haiou HealthViews: 71